Travere Boosts Cash Position As Investors Brace For Filspari Data (NASDAQ:TVTX)


Treatment of kidney diseases at urology. Urologist palpation woman

peakSTOCK/iStock via Getty Images

Introduction

Travere Therapeutics (NASDAQ:TVTX), a San Diego-based biopharmaceutical company, specializes in developing and delivering treatments for rare kidney, liver, and metabolic diseases. They recently received FDA accelerated approval for their lead product, sparsentan, targeting specific kidney disorders, and are also



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *